FDA Drug Recalls

Recalls / Class II

Class IID-0430-2021

Product

edarbyclor Azilsartan Medoxomil and Chlorthalidone Tablets 40 mg*/12.5 mg 30 Tablets Rx Only NDC 60631-412-30 Manufactured for: arbor Pharmaceuticals, LLC. Atlanta, GA 30328

Brand name
Edarbyclor
Generic name
Azilsartan Kamedoxomil And Chlorthalidone
Active ingredients
Azilsartan Kamedoxomil, Chlorthalidone
Route
Oral
NDCs
60631-412, 60631-425
FDA application
NDA202331
Affected lot / code info
78520

Why it was recalled

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Recalling firm

Firm
Cardinal Health Inc.
Manufacturer
Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
7000 Cardinal Pl, N/A, Dublin, Ohio 43017-1091

Distribution

Quantity
244 bottles
Distribution pattern
FL, GA, SC

Timeline

Recall initiated
2021-03-15
FDA classified
2021-05-24
Posted by FDA
2021-06-02
Terminated
2024-06-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0430-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Edarbyclor · FDA Drug Recalls